Characteristics of medical school faculty members serving on institutional review boards: Results of a national survey

Academic Medicine

Volumn 78, Issue 8, 2003, Pages 831-836

  Campbell, Eric G ^a,b   Weissman, Joel S ^c   Clarridge, Brian ^c   Yucel, Recai ^a   Causino, Nancyanne ^c   Blumenthal, David ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Institute for Health Policy   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BOARD OF TRUSTEES; CLINICAL RESEARCH; DATA ANALYSIS; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MEDICAL SCHOOL; PRIORITY JOURNAL; RANDOMIZATION; STANDARDIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TEACHING HOSPITAL; UNITED STATES; UNIVERSITY;

EID: 0042527710     PISSN: 10402446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001888-200308000-00019     Document Type: Article

References (16)

1. Commonwealth Fund Task Force on Academic Health Centers. From Bench to Bedside: Preserving the Research Mission of Academic Health Centers. New York: The Commonwealth Fund, 1999.
2. Institute of Medicine. Preserving Public Trust: Accreditation and Human Research Participant Protection Programs. Washington, DC: National Academy Press, 2001.
3. National Institutes of Health. Final Report: Evaluation of the NIH Implementation of Section 491 of the Public Health Service Act, Mandating a Program of Protection for Research Subjects. Arlington, VA: National Institutes of Health, 1998.
4. Christian MC, Goldberg JL, Killen J, et al. A central institutional review board for multi-institutional trials. N Engl J Med. 2002;346:1405-8.
5. Shalala D. Protecting research subjects: what must be done. N Engl J Med. 2000;343:808-10.
6. Angell M. Is academic medicine for sale? N Engl J Med. 2000;342:1516-8.
7. Gifford AL, Cunningham WE, Heslin KC, et al. Participation in research and access to experimental treatments by HIV-infecred patients. N Engl J Med. 2002;346:1373-82.
8. Kaplan S, Brownlee S. Dukes hazards: did medical experiments put patients needlessly at risk? US News & World Report, 1999 May 24;66-70.
9. Marshall E. Report of clinical trial volunteer's death. Science Now 〈http://sciencenow. sciencemag.org/cgi/content/full/2001/716/1〉. Accessed 5/24/02.
10. Lemmens T, Freedman B. Ethics review for Conflict of interest and commercial research review boards. Milbank Q. 2000;78:547-84, iii-iv.
11. Campbell EG, Weissman JS, Causino N, Blumenthal D. Data-withholding in academic medicine: characteristics of faculty denied access to research results and biomaterials. Research Policy. 2000;29:303-12.
12. Blumenthal D, Causino N, Campbell EG, Weissman JS. The relationship of market forces to the satisfaction of faculty at academic health centers. Am J Med. 2001;111:333-40.
13. Ludmerer KM. Time to Heal: American Medical Education from the Turn of the Century to the Era of Managed Care. Oxford and New York: Oxford University Press, 1999.
14. Palepu A, Carr PL, Friedman RH, Amos H, Ash AS, Moskowitz MA. Minority faculty and academic rank in medicine. JAMA. 1998;280:767471.
15. Blumenthal D, Campbell EG, Causino N, Louis KS. Participation of life-science faculty in research relationships with industry. N Engl J Med. 1996;335:1734-9.
16. Blumenthal D, Campbell EG, Anderson MS, Causino N, Louis KS. Withholding research results in academic life science. Evidence from a national survey of faculty. JAMA. 1997;277:1224-8.